Share Twitter LinkedIn Facebook Email Deepa Jeyakumar, MD, from UC Irvine Health talks about trying to understand the role of CPX-351 and if can be used as an outpatient for newly-diagnosed AML at MOASCs Spotlight On® Hematology in Huntington Beach.
FDA grants accelerated approval to ponatinib (ICLUSIG®) with chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia Acute Lymphoblastic Leukemia 3 Mins Read
FDA Approves Inotuzumab Ozogamicin (BESPONSA) for Acute Lymphoblastic Leukemia in Pediatric Patients [Exclusive Video] Acute Lymphoblastic Leukemia 3 Mins Read
Spotlight on CAR T-cell Therapy in 2024: Advances & Clinical Insights Acute Lymphoblastic Leukemia 3 Mins Read